E-learning Role of CETP inhibitors in cardiovascular risk reduction - Will lessons from the past lead to future success? - PACE-CME

This course consists of 3 parts.

Late-Breaking Clinical Trial and Clinical Science Special Reports Abstracts From the American Heart Association's Scientific Sessions 2016; Late-Breaking Abstracts in Resuscitation Science From the Resuscitation Science Symposium 2016

Role of CETP Inhibitors in Cardiovascular Risk Reduction: Will Past Failures Lead to Future Success?

Previous Distinguished Scientist Recipients - Professional Heart Daily

PACE-CME: Physicians' Academy for Cardiovascular Education op LinkedIn: Preventing CKD in patients with diabetes - Exploring the current and…

CETP inhibition - PACE-CME

EAVA cardiorisk@Egypt

Not baseline but time-dependent erythropoiesis-stimulating agent responsiveness predicts cardiovascular disease in hemodialysis patients receiving epoetin beta pegol: A multicenter prospective PARAMOUNT-HD Study - ScienceDirect

Role of CETP inhibitors in cardiovascular risk reduction - Will lessons from the past lead to future success? - PACE-CME

Exploring New Models for Cardiovascular Risk Reduction: The Heart Outcomes Prevention and Evaluation 4 (HOPE 4) Canada Pilot Study - ScienceDirect

Forecasting the Future of Cardiovascular Disease in the United States

Advanced-Database-Systems/Project2/Health-diabetes.org.txt at master · JFulgoni/Advanced-Database-Systems · GitHub